Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation [Yahoo! Finance]
Anebulo Pharmaceuticals, Inc. (ANEB)
Company Research
Source: Yahoo! Finance
For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. So, the natural question for Anebulo Pharmaceuticals NASDAQ:ANEB ) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. View our latest analysis for Anebulo Pharmaceuticals Does Anebulo Pharmaceuticals Have A Long Cash Runway? A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. In March 2024, Anebulo Pharmaceuticals had US
Show less
Read more
Impact Snapshot
Event Time:
ANEB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANEB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANEB alerts
High impacting Anebulo Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANEB
News
- Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $8.00 price target on the stock.MarketBeat
- Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates [Yahoo! Finance]Yahoo! Finance
- Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent UpdatesBusiness Wire
- Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $8.00 price target on the stock.MarketBeat
- Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent UpdatesBusiness Wire
ANEB
Earnings
- 5/15/24 - Beat
ANEB
Sec Filings
- 11/13/24 - Form 10-Q
- 11/13/24 - Form 8-K
- 10/17/24 - Form 8-K
- ANEB's page on the SEC website